News Spexis AG

Equities

POLN

CH0106213793

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
0.059 ^CHF	+0.34%		+14.34%	+43.90%

Apr. 17	Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis	MT
Apr. 17	Swiss Court OKs Moratorium Extension for Spexis	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis	Apr. 17	MT
Swiss Court OKs Moratorium Extension for Spexis	Apr. 17	MT
Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera	Apr. 17	EQ
Basilea Pharmaceutica Receives Grant for Antibiotics Program	Apr. 09	MT
Ascom Hires New CFO	Mar. 21	MT
Spexis Completes CHF2 Million Sale of Antibiotics Program to Basilea	Feb. 08	MT
Spexis announces closing of sale of preclinical antibiotics program to Basilea	Feb. 08	EQ
Basilea Pharmaceutica to Buy Preclinical Antibiotics Program Targeting Gram-negative Bacteria from Spexis	Jan. 15	MT
Spexis announces sale of preclinical antibiotics program to Basilea	Jan. 15	EQ
Spexis Secures Debt-restructuring Moratorium From Swiss Court	Dec. 05	MT
Spexis is Granted Debt-Restructuring Moratorium	Dec. 05	EQ
Spexis Seeks Loan Restructuring to Support Cystic Fibrosis Drug Study	Nov. 29	MT
Spexis Provides Update Regarding Debt-Restructuring Moratorium	Nov. 29	EQ
Spexis to File for Debt-restructuring Moratorium in Switzerland; Stock Sinks	Nov. 08	MT
Spexis to file an application for a debt-restructuring moratorium	Nov. 08	EQ
Spexis CFO to Step Down, Interim CFO Named	Nov. 01	MT
Spexis Announces Changes to the Executive Committee	Nov. 01	EQ
Spexis Announces Changes to the Executive Committee	Nov. 01	AQ
Spexis AG Announces Executive Changes, Effective December 1, 2023	Nov. 01	CI
Muriel Fleming Joins Spexis AG as Executive Committee, Effective December 1, 2023	Nov. 01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Spexis AG

Equities

POLN

CH0106213793

Summary

Filters